Suven Life Sciences Ltd., a Hyderabad, India company that has made its name in bulk actives, drug intermediates and fine chemicals, was granted two patents in China for new chemical entities. The two molecules, which belong to the class of 5-HT compounds, are aimed at treating disorders associated with neurodegenerative diseases. The two patents are valid until 2023 and 2024 respectively. More details...